Cargando…
ZNF213 negatively controls triple negative breast cancer progression via Hippo/YAP signaling
Breast cancer is one of the most commonly diagnosed malignancies worldwide, while the triple negative breast cancer (TNBC) is the most aggressive and virulent subtype in breast cancers. Compared with luminal type breast cancers, which could be well controlled by endocrine treatment, TNBC is worse in...
Autores principales: | Liu, Yun, Su, Peng, Zhao, Wuchen, Li, Xin, Yang, Xiao, Fan, Jianing, Yang, Huijie, Yan, Cheng, Mao, Lanzhi, Ding, Yinlu, Zhu, Jian, Niu, Zhiguo, Zhuang, Ting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253295/ https://www.ncbi.nlm.nih.gov/pubmed/33939216 http://dx.doi.org/10.1111/cas.14916 |
Ejemplares similares
-
ZNF213 Facilitates ER Alpha Signaling in Breast Cancer Cells
por: Yang, Huijie, et al.
Publicado: (2021) -
RBCK1 is an endogenous inhibitor for triple negative breast cancer via hippo/YAP axis
por: Li, Zhongbo, et al.
Publicado: (2022) -
RNF181 modulates Hippo signaling and triple negative breast cancer progression
por: Zhou, Rui, et al.
Publicado: (2020) -
RNF31 represses cell progression and immune evasion via YAP/PD-L1 suppression in triple negative breast Cancer
por: Yang, Huijie, et al.
Publicado: (2022) -
Regulation of the Hippo/YAP axis by CXCR7 in the tumorigenesis of gastric cancer
por: Wang, Tianshi, et al.
Publicado: (2023)